Interventional Cardiology Highlights: FDA clears new guidewire | Innovation in the cath lab | Managing SCAD

News You Need to Know Today

Wednesday, June 14, 2023

Editor's Choice: Interventional Cardiology

FDA clears new guidewire used for valve delivery and ventricular pacing during TAVR, BAV procedures

The device, now on display at TVT 2023 in Phoenix, is scheduled to begin hitting the market in the months ahead.

The Wattson temporary pacing guidewire from Teleflex

FDA clears new guidewire used for valve delivery and ventricular pacing during TAVR, BAV procedures

The device, now on display at TVT 2023 in Phoenix, is scheduled to begin hitting the market in the months ahead.

Interventional cardiologists perform world’s first TAVR with new embolic protection device

The device, designed with improved filtration and stability in mind, is now being investigated as part of a new pilot study.

The EnCompass Technologies F2 embolic filter device is designed to limit the risk of stroke and other severe brain injuries during TAVR.

Interventional cardiologists perform world’s first TAVR with new embolic protection device

The device, designed with improved filtration and stability in mind, is now being investigated as part of a new pilot study.

Innovation in the cath lab: Cardiologists develop, perform new interventional heart procedure

Interventional cardiologists in Detroit developed the new technique with a specific patient in mind. One specialist described it as an "exciting breakthrough."

Innovation in the cath lab: Cardiologists develop, perform new interventional heart procedure

Interventional cardiologists in Detroit developed the new technique with a specific patient in mind. One specialist described it as an "exciting breakthrough."

Management of patients with SCAD

Malissa Wood, MD, co-director of Corrigan Women’s Heart Health Program at Massachusetts General Hospital, shares some of the latest data from the iSCAD Registry.

Malissa J. Wood, MD, associate chief of cardiology for diversity and equity, and co-director, Corrigan Women’s Heart Health Program, Massachusetts General Hospital, spoke with Cardiovascular Business to explains some of the latest data from the iSCAD Registry presented at the American College of Cardiology 2023 meeting. She also discussed how these patients are currently diagnosed and and managed. #SCAD

Management of patients with SCAD

Malissa Wood, MD, co-director of Corrigan Women’s Heart Health Program at Massachusetts General Hospital, shares some of the latest data from the iSCAD Registry.

‘Promising’ results as first patients undergo PCI with next-generation pVAD device

The new product from California-based Supira Medical was designed to limit hemolysis and other complications among patients undergoing high-risk PCI or in cardiogenic shock

‘Promising’ results as first patients undergo PCI with next-generation pVAD device

The new product from California-based Supira Medical was designed to limit hemolysis and other complications among patients undergoing high-risk PCI or in cardiogenic shock

Conformal Medical raises $35M to continue development, research of next-gen LAAO device

The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

The CLAAS device from Conformal Medical. The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

Conformal Medical raises $35M to continue development, research of next-gen LAAO device

The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

Medtronic’s Harmony TPV system linked to ‘encouraging’ 1-year outcomes in new pooled analysis

The new study, based on “the largest cohort to date of Harmony TPV recipients," was published in JACC: Cardiovascular Interventions.

The Medtronic Harmony transcatheter pulmonary valve on display at ACC 2022. The U.S. Food and Drug Administration (FDA) has announced that Medtronic is recalling the delivery catheter from its Harmony transcatheter pulmonary valve (TPV) system due to a risk of the piece breaking during use.

Medtronic’s Harmony TPV system linked to ‘encouraging’ 1-year outcomes in new pooled analysis

The new study, based on “the largest cohort to date of Harmony TPV recipients," was published in JACC: Cardiovascular Interventions.

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

Editor's Choice: Interventional Cardiology

Recent Newsletters